LAB

NASDAQStock

Standard BioTools Inc.

$0.93+0.00 (+0.47%)

52-Week Range

$0.92
$1.68

Key Stats

Market Cap

359.5M

P/E Ratio

Dividend Yield

Beta

1.37

Volume

1.6M

Avg Volume

3.0M

Performance

1M

-16.17%

3M

-38.38%

6M

-32.08%

YTD

-26.73%

1Y

-18.38%

3Y

-54.83%

5Y

-75.51%

Price Chart

ETF Exposure

LAB is held by 61 ETFs

ETFFund NameWeight
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About LAB ETF Exposure

Standard BioTools Inc. (LAB) is held by 61 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 359.5M, LAB is a widely held institutional stock. The stock currently trades at $0.93. Investors can gain exposure to LAB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LAB, sorted by portfolio weight.